|
|
2015 EpiQuery Surveillance Data Now Available!
Use EpiQuery, an online interactive health data system, to find Hep B and Hep C prevalence estimates, rates over time, bar charts, neighborhood maps, and more. Click "Communicable Disease Surveillance Data" under “Surveillance Modules.”
|
|
|
Hep Free NYC News
Meeting Highlights | Aug 16 Staten Island Hep C Task Force. Presentations: New Brightpoint Health Clinic in Staten Island, Addressing Staten Island's Opioid Epidemic (Tackling Youth Substance Abuse), NYC Hep C Peer Navigation Program at CHASI, and Hep B and C Testing and Care Locations Referral Card.
|
|
|
Action
Students: Join the revitalized Team HBV NYC Student Initiative! Contact Giyoung Lee, Korean Community Services, to get involved.
Patients: Take the Coverage for Hep C Treatment survey from Hepatitis Foundation International.
Advocates: Watch the September 9 Hep C Treatment Access: State Level Successes webinar (1 - 2:30 PM) by National Viral Hepatitis Roundtable.
Join the Hep C Patient Consumer Committee to learn about current treatment options, policy updates, and how to advocate for affordable and accessible treatment. Organized by Carlos Rosario, VOCAL-NY.
|
|
Hep Free NYC Program Feature: Meet CBWCHC
|
|
Janice Lyu, Hep B Program Associate at the Charles B. Wang Community Health Center (CBWCHC), tells us about CBWCHC's Check Hep B Patient Navigation Program.
|
|
Describe a typical day for CBWCHC's Check Hep B Patient Navigation Program.
A typical day for care managers/patient navigators of the Check Hep B Patient Navigation Program entails learning about patients' and family members’ HBV history, providing counseling/education in person and appointment/medication adherence reminders over the phone. And most importantly, answering any questions that patients might have about their hep B and providing available resources for those who need assistance with their care.
|
|
What's your favorite Hep Free NYC moment?
We enjoy the NYC Hep B Coalition meetings since members provide insights from their organizations, including any care supports and updates that are available, and the
|
|
|
opportunity to collaborate to enhance hep B awareness in communities. We, particularly, appreciated and were thrilled to have Dr. Perry Pong, CBWCHC Chief Medical Officer, represent the Chinese American and other vulnerable populations at the May Hepatitis Awareness Press Conference in City Hall.
What do you think we need to achieve a Hep Free NYC?
We believe it is important to offer more complete awareness, education, and resources that support susceptible populations: AAPI, those foreign born living in NYC and, especially, women of childbearing age, pregnant, or entering postpartum, and their partners/close contacts to prevent vertical transmission since it is one of the leading cause of hep B transmission.
Want to learn more about what CBWCHC is doing?
Get in touch with Janice.
|
|
Resources
Check out New York Health Works, a resource for hepatitis advocacy.
|
|
Now Enrolling Patients: Project INSPIRE Hep C Care Coordination Program
|
|
Read more about the Project INSPIRE in this Huffington Post blog post. Now enrolling patients, refer your patients today!
|
|
Articles
Impact of hepatitis B on mortality and specific causes of death in adults with and without HIV co-infection in NYC, 2000-2011. Epidemiol Infect. August 2016. HBV disproportionately impacts two subgroups: Chinese immigrants and HIV-infected individuals. These two subgroups are geographically clustered in different neighbourhoods of NYC.
Highly curative hep C treatment safe, effective for drug users. Ann Int Med, August 2016. 91.5 percent of the patients in the immediate treatment group achieved sustained virologic response, regardless of ongoing drug use.
Many people in the US with chronic hepatitis B not being properly monitored. aidsmap.com. Analysis of the records of over 2000 people followed for six years showed that a quarter did not have an annual assessment of a key marker of liver function, only a third had yearly measurement of hepatitis B virus (HBV) DNA, and that 11% of people with cirrhosis had never had a liver ultrasound.
|
|
|
|
|
|